U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. OII Inspectorates
  6. Office of Medical Device and Radiological Health Inspectorate (OMDRHI)
  7. UGA/FDA 9th Annual Medical Device Regulations Conference - 11/15/2022
  1. Office of Medical Device and Radiological Health Inspectorate (OMDRHI)

Joint Regulatory | In Person

Event Title
UGA/FDA 9th Annual Medical Device Regulations Conference
November 15 - 16, 2022

Scheduled

Date:
November 15 - 16, 2022

UGA-FDA Medical Devices Conference Banner 2022

Virtual and In-Person Event

Location: University of Georgia Center for Continuing Education and Hotel in Athens, GA and Online via Zoom 

The Board of Regents of the University System of Georgia by and on behalf of the University of Georgia College of Pharmacy, Institute of International Biomedical Regulatory Sciences (“UGA”) and the Atlanta District of the Food and Drug Administration (“FDA”) are co-sponsoring the 9th Annual FDA/UGA Medical Device Regulations Conference for the medical device industry and those who interact with them.

UGA College of Pharmacy jointly developed the Medical Device Regulations Conference with FDA to facilitate understanding and collaboration between highly experienced professionals and technical experts from the FDA and industry on medical device issues. This conference carries out FDA’s mission to protect the public health and fulfill UGA’s educational and service missions.

Through a series of plenary and sessions, this conference will provide opportunities for attendees to learn about critical issues and current thinking in medical device regulations.

Goals and Objectives

The Medical Device Conference was established to provide educational and networking opportunities to help shape the future of medical device advancement from a regulatory science perspective. Using a tutorial approach, experienced leaders from the FDA, industry, and academia will present and engage the audience on issues related to strategic and tactical implications of FDA’s medical device regulations.
Aligned with the strategic priorities of the FDA, this conference seeks strategic solutions to complicated issues.

These challenges include:

  • Designing products with the patients in mind 
  • Addressing compliance and submission concerns 
  • Risk management throughout the life cycle of the device 
  • Risk management as part of design control 
  • Human Factors/Usability testing as part of risk management 
  • Current regulatory trends in the medical device industry 

View / download agenda.

Visit: https://www.fda.gov/about-fda/ora-program-areas/medical-device-radiological-health for additional information on ORA’s Medical Device & Radiological Health program area.

Contacts: 

FDA: Blake Bevill Blake.Bevill@fda.hhs.gov 

UGA: Grace Gowda Grace.Gowda@uga.edu 

 

Participation in this conference supports objectives set forth in section 406 of the FDA Modernization Act of 1997 (21 U.S.C. 393), which includes working closely with stakeholders and maximizing the availability and clarify of information to stakeholders and the public. This conference is also consistent with the Small Business Regulatory Enforcement Act of 1996 (Public Law 104-121), as an example of outreach activities by Government agencies to small businesses. 

Back to Top